ProShare Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-16,603
| Closed | -$871K | – | 2119 |
|
|
2020
Q3 | $871K | Sell |
16,603
-20,186
| -55% | -$836K | ﹤0.01% | 763 |
|
|
2020
Q2 | $1.22M | Buy |
36,789
+12,677
| +53% | +$404K | 0.01% | 654 |
|
|
2020
Q1 | $656K | Sell |
24,112
-13,755
| -36% | -$383K | ﹤0.01% | 678 |
|
|
2019
Q4 | $747K | Sell |
37,867
-2,572
| -6% | -$41.1K | ﹤0.01% | 906 |
|
|
2019
Q3 | $524K | Sell |
40,439
-1,482
| -4% | -$17.9K | ﹤0.01% | 965 |
|
|
2019
Q2 | $522K | Sell |
41,921
-4,956
| -11% | -$65.8K | ﹤0.01% | 995 |
|
|
2019
Q1 | $681K | Buy |
46,877
+9,391
| +25% | +$120K | ﹤0.01% | 916 |
|
|
2018
Q4 | $414K | Sell |
37,486
-5,817
| -13% | -$81K | ﹤0.01% | 1017 |
|
|
2018
Q3 | $1.14M | Sell |
43,303
-1,915
| -4% | -$51.8K | 0.01% | 776 |
|
|
2018
Q2 | $925K | Sell |
45,218
-2,364
| -5% | -$50.7K | 0.01% | 861 |
|
|
2018
Q1 | $864K | Sell |
47,582
-7,117
| -13% | -$119K | 0.01% | 885 |
|
|
2017
Q4 | $763K | Buy |
54,699
+5,230
| +11% | +$70.7K | 0.01% | 945 |
|
|
2017
Q3 | $915K | Buy |
49,469
+3,897
| +9% | +$65.1K | 0.01% | 759 |
|
|
2017
Q2 | $770K | Sell |
45,572
-1,764
| -4% | -$26.8K | 0.01% | 818 |
|
|
2017
Q1 | $632K | Sell |
47,336
-11,445
| -19% | -$179K | 0.01% | 927 |
|
|
2016
Q4 | $885K | Buy |
58,781
+6,499
| +12% | +$85.8K | 0.01% | 832 |
|
|
2016
Q3 | $611K | Sell |
52,282
-9,873
| -16% | -$116K | 0.01% | 870 |
|
|
2016
Q2 | $671K | Buy |
62,155
+2,076
| +3% | +$21.4K | 0.01% | 852 |
|
|
2016
Q1 | $555K | Sell |
60,079
-5,853
| -9% | -$63K | 0.01% | 951 |
|
|
2015
Q4 | $978K | Buy |
65,932
+6,446
| +11% | +$108K | 0.01% | 745 |
|
|
2015
Q3 | $976K | Sell |
59,486
-3,741
| -6% | -$76.6K | 0.01% | 679 |
|
|
2015
Q2 | $1.44M | Buy |
63,227
+8,361
| +15% | +$167K | 0.02% | 623 |
|
|
2015
Q1 | $834K | Buy |
54,866
+8,219
| +18% | +$107K | 0.01% | 937 |
|
|
2014
Q4 | $562K | Sell |
46,647
-841
| -2% | -$9.61K | 0.01% | 1135 |
|
|
2014
Q3 | $539K | Sell |
47,488
-9,799
| -17% | -$112K | 0.01% | 1359 |
|
|
2014
Q2 | $692K | Sell |
57,287
-31,672
| -36% | -$374K | 0.01% | 1376 |
|
|
2014
Q1 | $1.04M | Buy |
88,959
+62,017
| +230% | +$1.05M | 0.01% | 1281 |
|
|
2013
Q4 | $476K | Sell |
26,942
-22,267
| -45% | -$374K | 0.01% | 1075 |
|
|
2013
Q3 | $708K | Buy |
49,209
+7,197
| +17% | +$110K | 0.02% | 1156 |
|
|
2013
Q2 | $633K | Buy |
+42,012
| New | +$554K | 0.01% | 1142 |
|
ProShare Advisors's MNTA Position: Q4 2020 in Review
ProShare Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 16,603 shares — an estimated $871K sold.
ProShare Advisors first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $1.44M in Q2 2015. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- ProShare Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- ProShare Advisors sold 16,603 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $871K.
- ProShare Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- ProShare Advisors's Momenta Pharmaceuticals, Inc. position peaked at $1.44M in Q2 2015.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on ProShare Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.